Your session is about to expire
← Back to Search
PCR-based Test
Serology test using blood for COVID-19 (CATCH COVID-19 Trial)
Phase 1
Waitlist Available
Research Sponsored by Texas Cardiac Arrhythmia Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
CATCH COVID-19 Trial Summary
This trial will compare how well two types of tests can detect COVID-19 infection, and will also look at how these levels of antibodies change over time.
Eligible Conditions
- COVID-19
- Coronavirus
CATCH COVID-19 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
detection of viral infection using serology and viral-RNA detection kits
Secondary outcome measures
Temporal trend of antibodies in blood
CATCH COVID-19 Trial Design
3Treatment groups
Active Control
Group I: Serology test using bloodActive Control1 Intervention
Group II: Viral RNA test using nasopharyngeal swabActive Control1 Intervention
Group III: Viral RNA test using sputumActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Texas Cardiac Arrhythmia Research FoundationLead Sponsor
37 Previous Clinical Trials
13,280 Total Patients Enrolled
4 Trials studying COVID-19
5,260 Patients Enrolled for COVID-19
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger